Results 131 to 140 of about 3,226 (196)

Drug-induced gingival overgrowth in renal transplants patients. [PDF]

Open Med (Wars)
Lomelí-Martínez SM, Martínez-Nieto M, Rodríguez-Montaño R, Alarcón-Sánchez MA, Varela Hernández JJ, Gutiérrez-Maldonado AF, Gomez-Mireles JC, Sánchez CR, Torres-Sánchez ED.   +8 more
europepmc   +1 more source

Eosinophilic fasciitis. [PDF]

Med Clin (Barc)
Pinal-Fernández I, Milisenda JC, Selva-O'Callaghan A.   +2 more
europepmc   +1 more source

How short peptides interact with oral cells? A systematic review. [PDF]

BMC Oral Health
Tetè G, Trofimov A, Vinskid NC, Tafuri G, Profili F, Sinjari B.   +5 more
europepmc   +1 more source

Personalized dialysis: use of ultrasonography as a guide for ultrafiltration in hemodialysis during pregnancy. Case report

Rev Colomb Obstet Ginecol
Martín Arsanios D, Medina LD, Cantillo Vargas MJ, Alberto González C.   +3 more
europepmc   +1 more source

[Severe hypereosinophilia as a paraneoplastic syndrome in a patient with differentiated thyroid cancer] [PDF]

Rev Fac Cien Med Univ Nac Cordoba
Videla EK, De la Torre B, Ferrada P, Miller J, Torres E, Álvarez A, Herrera J.   +6 more
europepmc   +1 more source

[Survival after hematopoietic stem cell transplantation with identical and haploidentical donors]. [PDF]

Rev Med Inst Mex Seguro Soc
Jiménez-Ochoa MA, Contreras-Serratos MM, González-Bautista ML, López-Macías C, Arriaga-Pizano LA, Aguilar-Marquez ME.   +5 more
europepmc   +1 more source

Age and Epstein-Barr viral load at diagnosis of post-transplant lymphoproliferative disease are associated with patient survival in kidney transplant recipients. [PDF]

J Bras Nefrol
Francisco D, Requião-Moura L, Nogueira R, Alencar RN, Foresto RD, Tedesco-Silva H, Pestana JM.   +6 more
europepmc   +1 more source

Safety and immunogenicity of the yellow fever vaccine for patients with end-stage renal disease. [PDF]

J Bras Nefrol
Distenhreft JIQ, Couto-Lima D, Andreazzi CS, Thomazini JFRC, Vasconcellos Filho LM, Falqueto A, Luchi WM.   +6 more
europepmc   +1 more source

Costo per NNT di upadacitinib nel trattamento dei pazienti con dermatite atopica da moderata a severa in Italia. [PDF]

Glob Reg Health Technol Assess
Chiricozzi A, Costanzo A, Levi A, Parretta F, Ravasio R.   +4 more
europepmc   +1 more source